Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2

Condition:   Heart Failure Interventions:   Drug: LCZ 696;   Drug: Icatibant;   Drug: placebo;   Drug: Para-aminohippurate;   Drug: Iohexol Sponsor:   Vanderbilt University Medical Center Not yet recruiting

Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials